Search information
OnKure Therapeutics, Inc.
Companies
"Incentive"
Keywords
Tables in SEC filings
Source
Name and Principal Position(s) | Year | Salary | Option Awards (1) | Non-Equity Incentive Plan Compensation (2) | All Other Compensation | Total | ||||||||||||||||
Gregory J. Flesher | 2023 | $ | 563,942 | $ | — | $ | — | $ | 5,762 | (3) | $ | 569,704 | ||||||||||
President and Chief Executive Officer | 2022 | $ | 545,000 | $ | 393,000 | $ | 245,300 | $ | 10,152 | $ | 1,193,452 | |||||||||||
Alejandro Dorenbaum, M.D. | 2023 | $ | 460,471 | $ | — | $ | — | $ | 5,758 | (3) | $ | 466,229 | ||||||||||
Chief Medical Officer | ||||||||||||||||||||||
Ashley F. Hall, J.D. | 2023 | $ | 441,346 | $ | — | $ | — | $ | 5,758 | (3) | $ | 447,104 | ||||||||||
Chief Development Officer | 2022 | $ | 420,000 | $ | 163,750 | $ | 151,200 | $ | 90,354 | $ | 825,304 |
Option Awards (1) | Stock Awards (2) | |||||||||||||||||||||||||
Name | Grant Date | Number of Securities Underlying Unexercised Options Vested (#) | Number of Securities Underlying Unexercised Options Unvested (#) | Option Exercise Price Per Share ($) | Option Expiration Date | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#) | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) (3) | |||||||||||||||||||
Gregory J. Flesher | 12/9/22 | (4) | 75,000 | 225,000 | $ | 1.80 | 12/8/32 | — | $ | — | ||||||||||||||||
President and Chief Executive Officer | 12/10/21 | (5) | 100,000 | 100,000 | $ | 6.69 | 12/9/31 | — | $ | — | ||||||||||||||||
12/10/21 | (6) | — | — | $ | — | — | 100,000 | $ | 160,000 | |||||||||||||||||
1/21/21 | (7) | 811,415 | 241,232 | $ | 4.88 | 1/20/31 | — | $ | — | |||||||||||||||||
Alejandro Dorenbaum, M.D. | 12/9/22 | (4) | 31,250 | 93,750 | $ | 1.80 | 12/8/32 | — | $ | — | ||||||||||||||||
Chief Medical Officer | 12/10/21 | (5) | 50,000 | 50,000 | $ | 6.69 | 12/9/31 | — | $ | — | ||||||||||||||||
12/10/21 | (8) | — | — | $ | — | — | 30,000 | $ | 48,000 | |||||||||||||||||
1/21/21 | (9) | 75,422 | 25,141 | $ | 4.88 | 1/20/31 | — | $ | — | |||||||||||||||||
6/26/19 | (9) | 41,119 | — | $ | 3.76 | 6/25/29 | — | $ | — | |||||||||||||||||
4/5/18 | (7) | 15,033 | — | $ | 1.97 | 4/4/28 | — | $ | — | |||||||||||||||||
Ashley F. Hall, J.D. | 12/9/22 | (4) | 15,625 | 93,750 | $ | 1.80 | 12/8/32 | — | $ | — | ||||||||||||||||
Chief Development Officer | 11/12/21 | (7) | 97,500 | 82,500 | $ | 8.85 | 11/11/31 | — | $ | — | ||||||||||||||||
11/12/21 | (10) | — | — | $ | — | — | 30,000 | $ | 48,000 |